Surgical removal of a tumor arising from the soft tissues of the back or flank when the lesion measures 5 cm or greater in its greatest dimension.
Verified May 8, 2026 · 5 sources ↓
- Medicare
- $1,307.98
- Total RVUs
- 39.16
- Global, days
- 90
- Region
- Other
Documentation requirements
What must appear in the operative or office note to support the claim.
Source · Editorial brief grounded in 5 cited references ↓
- Measured tumor size in greatest dimension documented in the operative note — must be 5 cm or greater to support this code over 21935
- Tissue of origin specified (soft tissue of back or flank, not bone or spinal elements)
- Operative note names the surgical approach and depth of dissection, including any involvement of underlying fascia or muscle
- Pathology report confirming specimen identity, size, and diagnosis (benign vs. malignant) — required for ICD-10 assignment and payer audit defense
- Pre-operative imaging (MRI preferred) documenting lesion size and location relative to anatomic structures
- If modifier 22 is appended, a separate narrative explaining substantially increased operative work, including factors such as proximity to neurovascular structures, bleeding, or adherence to adjacent tissue
Applicable modifiers
Modifiers commonly billed with this code.
Source · AMA CPT modifier descriptors · CMS NCCI Policy Manual
What this code covers
Source · Editorial summary grounded in 5 cited references ↓
CPT 21936 covers open excision of a soft-tissue tumor of the back or flank with a greatest diameter of 5 cm or more. The size threshold is the single most critical coding determinant — anything under 5 cm routes to 21935. The tumor must originate from or involve the soft tissues of the posterior trunk; lesions arising from bone or involving the spine are coded elsewhere.
This code carries a 90-day global period. The operative day, the day-before visit, and all routine post-op care through day 90 are bundled. If you're seeing the patient for an unrelated problem during that window, append modifier 24 to the E/M. If the decision for surgery happened at a same-day or day-before visit, modifier 57 unlocks separate E/M payment. Staged or planned re-excision for margin clearance during the global uses modifier 58; an unplanned return to the OR for a related complication uses modifier 78.
Surgical oncology accounts for the majority of utilization. Pathology (26 for professional component) is separately reportable and essential — the operative note must specify the measured specimen size and tissue of origin to justify the code and support medical necessity. Payers routinely request pathology reports on audit to confirm the 5 cm threshold and the benign vs. malignant distinction, which drives ICD-10 selection.
RVU & reimbursement
Component RVUs and Medicare national rate. Actual payment varies by GPCI locality.
Source · CMS Physician Fee Schedule, RVU26A · January 2026
| Work RVU | 21.99 |
| Practice expense RVU | 11.94 |
| Malpractice RVU | 5.23 |
| Total RVU | 39.16 |
| Medicare national rate | $1,307.98 |
| Global period | 90 days |
Payment by site of service
Medicare pays different rates by setting. HOPD typically pays substantially more than ASC for the same procedure.
Source · CMS OPPS Addendum B·ASC HCPCS payment rates·2026
| Setting | Medicare rate (national) |
|---|---|
Office (PFS non-facility) Procedure performed in physician's office | $1,307.98 |
HOPD (APC 5073) Hospital outpatient department | $2,967.63 |
ASC (PI G2) Ambulatory surgical center (freestanding) | $1,248.36 |
Common denial reasons
The recurring reasons claims for CPT 21936 get rejected.
Source · Editorial brief grounded in CMS NCCI edits, AAOS coding appeals, and cited references ↓
- Tumor size not documented at or above 5 cm — payer downcodes to 21935 without a measured dimension in the operative note
- ICD-10 diagnosis code mismatched to site (back/flank) or malignancy status inconsistent with pathology report
- Separate E/M billed same-day without modifier 25, bundled into the global surgical package
- Pathology report absent from record at time of payer audit, triggering medical necessity denial
- Incorrect site modifier when bilateral or laterality-specific payer edits apply — LT/RT not appended when required by the payer
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 5 cited references ↓
01What is the size threshold that separates 21936 from 21935?
02Can I bill pathology separately from 21936?
03How does the 90-day global period affect post-op E/M visits?
04When should modifier 22 be appended to 21936?
05Is 21936 appropriate for tumors on the flank, or only the back?
06What ICD-10 codes pair with 21936?
07Can 21936 be billed with reconstruction codes if a flap or graft is required?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CMS Physician Fee Schedule 2026
- 02cms.govhttps://www.cms.gov/files/document/medicare-ncci-policy-manual-2024-chapter-4.pdf
- 03aaos.orghttps://www.aaos.org/globalassets/quality-and-practice-resources/coding-and-reimbursement/resident-guide/resident-guide_modifiers.pdf
- 04aaos.orghttps://www.aaos.org/quality/coding-and-reimbursement/
- 05aapc.comhttps://www.aapc.com/codes/cpt-codes/21936
Mira AI Scribe
Mira's AI scribe captures the measured tumor dimensions from dictation, the tissue layer of origin (subcutaneous, fascial, intramuscular), the approach used, and any factors increasing operative complexity — proximity to neurovascular structures, bleeding, or dense adhesions. That structured capture prevents the most common audit trigger: an operative note that states the tumor was 'large' without a recorded measurement, which hands the reviewer a path to downcode to 21935 or deny on medical necessity.
See how Mira captures CPT 21936 documentation